2024

1. Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study

   Circulation Research, Vol. 134, Núm. 4, pp. 411-424

2. Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes

   Nature Cardiovascular Research, Vol. 3, Núm. 2, pp. 203-220

3. Circadian Effects on Vascular Immunopathologies

   Circulation Research, Vol. 134, Núm. 6, pp. 791-809

4. Correction to: Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography (EJNMMI Physics, (2024), 11, 1, (12), 10.1186/s40658-024-00618-2)

   EJNMMI Physics

5. Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease

   Biomedicine and Pharmacotherapy, Vol. 173

6. Data source integration: a key tool for optimizing resources and prioritizing areas for improvement in clinical practice and epidemiology

   Revista Espanola de Cardiologia

7. Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography

   EJNMMI Physics, Vol. 11, Núm. 1

8. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline

   British Journal of Pharmacology

9. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling

   Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

10. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

11. MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension

    Science advances, Vol. 10, Núm. 3, pp. eadk6524

12. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 777-798

13. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

14. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

    European Journal of Heart Failure

15. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776

16. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors

    Biomedicine and Pharmacotherapy, Vol. 174

17. Retinal ganglion cells in a mouse model of Alzheimer's disease: A temporal study

    Acta Ophthalmologica

18. Secondary Prevention Therapies in Real-World Patients with Myocardial Infarction: Eligibility Based on Randomized Trials Supporting European and American Guidelines

    American Journal of Medicine, Vol. 137, Núm. 2, pp. 137-146.e10

19. Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology

    European Heart Journal: Acute Cardiovascular Care, Vol. 13, Núm. 1, pp. 36-45

20. Sudden cardiac death triggered by minimal alcohol consumption in the context of novel PPA2 mutations in 2 unrelated families

    Gene, Vol. 916